We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Building Tools to Support TB Research

News   Apr 18, 2017 | Original story from Notre Dame University

 
Building Tools to Support TB Research

Credit: Janice Haney Carr, Dr. Ray Butler, USCDCP

 
 
Advertisement
 

RELATED ARTICLES

Oxford's COVID-19 Vaccine Has 70% Efficacy Rate

News

There are now over 170 teams of researchers working to develop a vaccine for protection against COVID-19. Over the last few weeks, a number of groups shared interim analysis data on candidates that have reached Phase III clinical testing. The latest addition is the University of Oxford – in collaboration with the pharmaceutical company AstraZeneca – who today announce an efficacy of 70.4% for the candidate, ChAdOx1 nCoV-2019.

READ MORE

ChIP-Seq May Have Been Quantitative All Along

News

ChIP-seq provides invaluable insights into the underpinnings of health and disease, it also faces a frustrating challenge, but its results are often viewed as qualitative rather than quantitative, making interpretation difficult. A recent report suggests that ChIP-seq may have been quantitative all along.

READ MORE

A Paint Spot Can Tell Us More Than You'd Think

News

How much information can you get from a speck of purple pigment, no bigger than the diameter of a hair, plucked from an Egyptian portrait that’s nearly 2,000 years old? Plenty, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE